HER2CLIMB: Sequencing in Metastatic Breast Cancer
3 Tampilan
administrator
07/03/23
Given other methods used to treat HER2-positive metastatic breast cancer, Erika P. Hamilton, MD, considers tucatinib’s role in sequencing.
Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive
Menampilkan lebih banyak
Komentar Facebook
Tidak ada komentar yang ditemukan